OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Matt Bacso - IR, Gilmartin Group David Bailey - President and Chief Executive Officer Fred Hite - Chief Financial Officer and Chief Operating Officer Conference Call Participants Ryan Zimmerman - BTIG David Saxon - Needham & Company Sam Bardowski - Truist Daniel Stauder - JMP Securities Operator Good morning, and welcome to OrthoPediatrics Corporation Second Quarter 2022 Earnings Conference C ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Matt Bacso - IR, Gilmartin Group David Bailey - President and CEO Fred Hite - CFO and COO Conference Call Participants Matthew O'Brien - Piper Sandler Samuel Brodovsky - Truist Securities Mike Matson - Needham & Company Ryan Zimmerman - BTIG Dave Turkaly - JMP Securities Operator Welcome to the Q1 2022 OrthoPediatrics Corporation Earnings Conference Call. At this time, all participants are in a l ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

Washington, DC 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from _______ to _______ Commission file number 001-38242 ORTHOPEDIATRICS CORP. (Exact name of registrant as specified in its charter) Delaware 26-1761833 (State or other ...

OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2021 Earnings Conference Call March 3, 2022 8:00 AM ET Company Participants Matt Bacso - Investor Relations, Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Matthew O'Brien - Piper Sandler & Co. Rick Wise - Stifel Samuel Brodovsky - Truist Ryan Zimmerman - BTIG Mike Matson - Needham & Company Dave Turkaly - JMP Securities Operator Good morning and welcome to Or ...

("thoPediattrics" 2022 Investor Presentation www.OrthoPediatrics.com 0 0 0 0 0 0 Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of U.S. federal securities laws. You can identify forward-looking statements by the use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "believe," "estimate," "project," "target," "predict," "intend," "future," "goals," "potential," "objective," "would" and other similar ex ...

OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2021 Earnings Conference Call November 4, 2021 8:00 AM ET Corporate Participants Matt Bacso - IR, Gilmartin Group David Bailey - President and Chief Executive Officer Fred Hite - Chief Operating and Financial Officer Conference Call Participants Simran Kaur - Piper Sandler David Saxon - Needham Ryan Zimmerman - BTIG Sam Brodovsky - Truist Dave Turkaly - JMP Securities Operator Good afternoon, and welcome to the OrthoPediatrics Corporation's Third Quarter 2021 Earnings ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2021 Results Conference Call August 5, 2021 8:00 AM ET Company Participants Matt Bacso - Gilmartin Group David Bailey - President and Chief Executive Officer Fred Hite - Chief Operating and Financial Officer Conference Call Participants Drew Stafford - Piper Sandler Rick Wise - Stifel Ryan Zimmerman - BTIG Mike Matson - Needham Sam Brodovsky - Truist Daniel Stauder - JMP Securities Operator Good morning, and welcome to the OrthoPediatrics Corporation's Second Quarter 2 ...